Advice on the Safe Introduction and Continued Use of Isotretinoin in Acne in the U.K. 2010

    M. J. D. Goodfield, N. H. Cox, A. Bowser … A.D. Ormerod
    Studysummary This document discusses the British Association of Dermatologists' current perspective on isotretinoin, focusing on its known side effects, prescribing requirements, teratogenic risks, and the contentious link to mood changes, reporting no new research findings.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on doi.org →
    Discuss this study in the Community →

    Related research 1

    1. Isotretinoin-Unresponsive Acne as a Sign of a Congenital Disorder: A Case of 21-Hydroxylase Deficiency Dermatology Reports · 2023